2) diffuse large B-cell lymphoma
弥漫大B细胞型淋巴瘤
1.
Objective To evaluate the efficacy and toxicity of combination of Rituximab and CHOP regimen in diffuse large B-cell lymphoma(DLBCL).
目的研究利妥昔单抗联合CHOP方案治疗弥漫大B细胞型淋巴瘤的疗效和不良反应。
2.
Objective To observe the effect and toxicity of rituximab and CHOP regimen(R-CHOP) in the treatment of initially diagnosed diffuse large B-cell lymphoma.
目的观察利妥昔单抗联合CHOP方案(R-CHOP)治疗初治弥漫大B细胞型淋巴瘤的疗效以及毒副反应。
3) Large B Cell/Diffuse
大B细胞/弥漫性
5) diffuse large B-cell
弥漫大B细胞性
6) diffuse large B-cell lymphoma
弥漫大B细胞淋巴瘤
1.
PRDM1 expression and prognostic value in patients with diffuse large B-cell lymphoma;
PRDM1在弥漫大B细胞淋巴瘤中表达和预后意义的研究
2.
The molecular cytogenetic aberration analyzed by comparative genomic hybridization and its significance in diffuse large B-cell lymphoma;
用比较基因组杂交技术研究弥漫大B细胞淋巴瘤分子细胞遗传学异常及其意义(英文)
3.
Immunohistochemical profiles and their prognostic role in diffuse large B-cell lymphoma
弥漫大B细胞淋巴瘤的免疫学亚型与预后的关系
补充资料：大细胞未分化型肺癌
大细胞未分化型肺癌
large cell undifferentiated carcinoma of lung
是支气管肺癌的一种类型。由大小不一的多边形细胞组成，呈实体巢状排列。癌细胞核大，核仁大而明显，胞浆丰富。可发生在肺门附近或肺边缘的支气管。治疗以手术、放疗或化疗综合治疗。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条